Aptyx has appointed David Price as Chief Executive Officer, effective immediately. Price previously served as the medical device contract development and manufacturing organization’s Chief Financial Officer.
Price joined Aptyx in 2025 and has helped refine the company’s strategic priorities, strengthen operational execution and prepare the business for its next phase of growth. His background combines financial management with commercial and operational leadership.
As CEO, Price will focus on accelerating growth and strengthening Aptyx’s relationships with medical device companies. His priorities will also include operational excellence, leadership development and the continued expansion of the company’s technical capabilities.
Aptyx operates as a contract development and manufacturing organization, commonly known as a CDMO. It works with medical device and advanced manufacturing companies on product design, engineering, development and manufacturing.
Medical device companies frequently use CDMOs to access specialized manufacturing processes, engineering talent and quality systems without building every capability internally. These relationships can extend from early product development through scaled commercial production.
Aptyx plans to build on its existing engineering, manufacturing and quality infrastructure as it supports customers bringing new medical technologies to market. The company believes demand within the medical device sector creates opportunities to expand its customer partnerships and manufacturing programs.
Price succeeds into the CEO role with the support of Aptyx’s board and private equity backer TruArc Partners. The board cited his leadership, business judgment and commitment to the company’s employees, customers and growth strategy.
KEY QUOTES:
“David has earned the confidence of the Board through his leadership, business acumen, and clear commitment to our customers, employees, and growth strategy. He is the right leader to build on Aptyx’s strong foundation and accelerate the Company’s continued growth.”
John Pless, Co-Managing Partner of TruArc Partners
“I am honored to lead Aptyx at such an important stage in our growth. We operate in a dynamic medical device market with significant opportunities ahead.”
“With our talented team, technical capabilities, customer-centric culture, and commitment to the highest quality standards, Aptyx is well positioned to deliver innovative solutions and create long-term value for our employees, customers, and stakeholders.”
David Price, CEO of Aptyx
